Dr. Christopher Moertel
Claim this profileUniversity of Minnesota/Masonic Cancer Center
Area of expertise
Neurofibromatosis
Christopher Moertel has run 8 trials for Neurofibromatosis. Some of their research focus areas include:
Brain Tumor
Christopher Moertel has run 4 trials for Brain Tumor. Some of their research focus areas include:
Affiliated Hospitals
University Of Minnesota/Masonic Cancer Center
University Of Minnesota
Clinical Trials Christopher Moertel is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting
2 awards
Phase 3
Registry
for Peripheral Nerve Sheath Tumor
First, the investigators plan to use a retrospective analysis to determine the clinical landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor (MPNST) and precursor lesions (e.g., atypical or nodular plexiform neurofibromas). A worldwide database will be established, collecting, in a standardized manner, histologic, immunohistochemical, molecular, radiographic, treatment, and related clinical data from centers worldwide with expertise in these NF1-related cancers. Although retrospective in nature, the resulting data from this registry may reveal previously unanticipated patterns, similar to the INFACT effort outcome. This registry would then allow the acquisition of data associated with MPNST biospecimens collected under associated banks (frozen or paraffin-embedded, germline (or normal tissue DNA) samples, and any previously somatic whole-exome or whole-genome sequencing data for aggregate analyses). Second, the investigators plan to co-register patients to institutional banks in order to prospectively collect MPNST samples for analysis. These patients will be consented in order to collect the above information and for banking of tumor tissue and future studies that include genomic characterization of the tumors.
Recruiting
1 award
N/A
1 criteria
More about Christopher Moertel
Clinical Trial Related
6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Christopher Moertel has experience with
- Selumetinib
- Radiation Therapy
- Mirdametinib (PD-0325901)
- Curcumin
- High Phenolic Extra Virgin Olive Oil (HP-EVOO)
- Placebo
Breakdown of trials Christopher Moertel has run
Neurofibromatosis
Brain Tumor
Astrocytoma
Diffuse Hemispheric Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher Moertel specialize in?
Christopher Moertel focuses on Neurofibromatosis and Brain Tumor. In particular, much of their work with Neurofibromatosis has involved NF1 positive patients, or patients who are NF2 positive.
Is Christopher Moertel currently recruiting for clinical trials?
Yes, Christopher Moertel is currently recruiting for 3 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Christopher Moertel has studied deeply?
Yes, Christopher Moertel has studied treatments such as Selumetinib, Radiation Therapy, Mirdametinib (PD-0325901).
What is the best way to schedule an appointment with Christopher Moertel?
Apply for one of the trials that Christopher Moertel is conducting.
What is the office address of Christopher Moertel?
The office of Christopher Moertel is located at: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota 55455 United States. This is the address for their practice at the University of Minnesota/Masonic Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.